http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015091315-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate | 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0455de2aa8149108426157cd0732654 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2ca16035d1a6a981a3153219c3eb62e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2662fb48b6fc8ae7a1bfea2b4e448833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4417c50ea80edc602f1e716ea983061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0966cd7db6f01e4504041b23378579 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1aeefd25fdf8a0f5eb3a23e0be66e98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2948289dec96c72f6310b42b610bf3 |
| publicationDate | 2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015091315-A1 |
| titleOfInvention | Spiro[indolin-3,4'-piperidine] derivatives as gnrh receptor antagonists |
| abstract | Spiroindoline-piperidine derivatives of formula (I) as gonadotropin- releasing hormone (GnRH) receptor antagonists, process for their preparation and pharmaceutical compositions thereof, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selcted from the group of endometriosis, uterine fibroids, polycystic ovarian disease, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reproductive therapy such as in vitro fertilization). The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists. |
| priorityDate | 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1521.